Cargando…
The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation
The cyclic 3′,5′-adenosine monophosphate (cAMP) sensor enzyme, EPAC1, is a candidate drug target in vascular endothelial cells (VECs) due to its ability to attenuate proinflammatory cytokine signalling normally associated with cardiovascular diseases (CVDs), including atherosclerosis. This is throug...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753123/ https://www.ncbi.nlm.nih.gov/pubmed/29367551 http://dx.doi.org/10.3390/jcdd4040022 |